Tehrani Shabnam, Saffarfar Vida, Hashemi Ali, Abolghasemi Sara
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos. 2019 Mar;18(3):215-222.
Ventilator-Associated Pneumonia (VAP) occurs in hospitalized patients who have undergone intubation and mechanical ventilation for more than 48 hours. Patients referred to the Intensive Care Unit (ICU) are also affected by VAP due to specific conditions, especially by Gram-negative pathogens with advanced drug resistance. In this study, the pattern of antibiotic resistance of gram negative bacteria isolated from tracheal culture of VAP patients was investigated in ICU.
In this cross-sectional study, tracheal samples were collected from VAP patients admitted in the hospital's ICU from March 2017-February 2018. After isolation, bacterial isolates were identified using biochemical tests. Then, antimicrobial resistance pattern of these isolates was investigated using standard disc diffusion and E-test methods. Multiplex PCR were used to detect the -like, -like, OXA-24-like, and -like genes among () isolates.
A total of 29 bacterial isolates were isolated from ICU patients, which were ) and candida spp, with prevalence of 38, 27.5, 13.8, and 20.7%, respectively. Antibiotic susceptibility test of isolates indicated that almost all isolates showed Multi-Drug Resistance (MDR) pattern. The isolates were resistant to ciprofloxacin and piperacillin-tazobactam, but ampicillin-sulbactam and colistin had better results. Ciprofloxacin, meropenem and colistin were effective against isolates, but other antibiotics were less effective and Colistin, Levofloxacin (LVX) and Piperacilin/Tazobactam were the best antibiotics that were effective on the isolates of .
According to the present study, high resistance to most antibiotics in gram negative bacilli showed that antibiotic therapy should be based on the type of bacteria isolated by tracheal culture and, as far as possible, combination therapies should be used to maximize the coverage of other possible pathogens, and antibiotic resistance in ICU.
呼吸机相关性肺炎(VAP)发生在接受插管和机械通气超过48小时的住院患者中。因特定情况入住重症监护病房(ICU)的患者也会受到VAP影响,尤其是受到具有高度耐药性的革兰氏阴性病原体影响。在本研究中,对ICU中VAP患者气管培养分离出的革兰氏阴性菌的耐药模式进行了调查。
在这项横断面研究中,于2017年3月至2018年2月从医院ICU收治的VAP患者中采集气管样本。分离后,通过生化试验鉴定细菌分离株。然后,使用标准纸片扩散法和E-test法研究这些分离株的抗菌耐药模式。采用多重聚合酶链反应检测()分离株中的-like、-like、OXA-24-like和-like基因。
从ICU患者中共分离出29株细菌,分别为()和念珠菌属,患病率分别为38%、27.5%、13.8%和20.7%。分离株的药敏试验表明,几乎所有分离株都呈现多重耐药(MDR)模式。()分离株对环丙沙星和哌拉西林-他唑巴坦耐药,但氨苄西林-舒巴坦和黏菌素效果较好。环丙沙星、美罗培南和黏菌素对()分离株有效,但其他抗生素效果较差,黏菌素、左氧氟沙星(LVX)和哌拉西林/他唑巴坦是对()分离株有效的最佳抗生素。
根据本研究,革兰氏阴性杆菌对大多数抗生素的高耐药性表明,抗生素治疗应基于气管培养分离出的细菌类型,并且应尽可能采用联合治疗,以最大限度覆盖其他可能的病原体,以及应对ICU中的抗生素耐药性问题。